Forschung & Innovation
Publikationen

Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts.

#2002

#Cellular physiology and biochemistry

PMU Autor*innen
Markus Paulmichl, Markus Ritter

Alle Autor*innen
Johannes Fürst, Thomas Haller, Sabine Chwatal, Ewald Wöll, Peter C Dartsch, Martin Gschwentner, Anton Dienstl, Heinz Zwierzina, Florian Lang, Markus Paulmichl, Markus Ritter

Fachzeitschrift
Cellular physiology and biochemistry

Kurzfassung

Keywords

SMOOTH-MUSCLE-CELLS, GENE-EXPRESSION, TRANSGENIC MICE, PHASE-I, COENZYME-A REDUCTASE, GERANYLGERANYLTRANSFERASE-I INHIBITOR, PROTEIN TRANSFERASE INHIBITOR, INTRACELLULAR PH REGULATION, N-RAS, CA2+

Weitere Publikationen

#2026

#Originalarbeit

Dana Macejova, Jakub Kollar, Zdenek Dvorak, Daniela Schuster, Julius Brtko Tributyltin propionate and tributyltin salicylate represent novel RXR ligands, Retinoid X receptor ligands; Thyroid hormone receptors; Transcriptional activity; Tributyltin propionate; Tributyltin salicylate; Vitamin D(3)receptor;

#2025

#Originalarbeit

Olaf Rose, Kreshnik Hoti, Blete Isufi, Matthias Wachinger, Johanna Pachmayr, Alexander Hartl, Heinz Giesen, Stephanie Clemens Drug shortages

#2025

#Originalarbeit

Christopher Huken, Patrick Kutschar, Martin W. Schnell, Christine Dunger Burdens and coping strategies among geriatric care nurses during COVID-19: A factorial survey

Zurück zur Übersicht

Paracelsus Medizinische Privatuniversität Forschung & Innovation Publikationen

Simvastatin inhibits malignant transformation...